Physician profile
Anthony Gunawan
NPI 1386671386
$30,024.93
in general payments reported to CMS, 2019-2025
59 companies · $4,433 in 2025
The $4,433 reported for 2025 was more than what 91% of Cardiovascular Disease providers received nationally (typical 2025 total: $433).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $6,595 · 2020: $2,829 · 2021: $3,397 · 2022: $4,720 · 2023: $4,716 · 2024: $3,335 · 2025: $4,433.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $12K · Education: $99.99 · Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $16.91.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $12,367.58 |
| Education | $99.99 |
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $16.91 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astrazeneca Pharmaceuticals Lp | $5,101.52 | 2019-2025 | Farxiga, Wainua, Lokelma |
| Janssen Pharmaceuticals, INC | $2,981.77 | 2019-2024 | Xarelto |
| Novo Nordisk INC | $2,619.44 | 2019-2025 | Wegovy, Ozempic |
| Boston Scientific Corporation | $2,149.50 | 2019-2025 | Ilab Ultrasound Imaging System, General - Vascular Intervention, Emerge Push |
| Amgen INC. | $1,856.35 | 2019-2025 | Repatha, Repatha |
| Medtronic, INC. | $1,362.48 | 2022-2025 | Onyx Frontier, Symplicity G3, Micra |
| E.R. Squibb & Sons, L.L.C. | $1,154.85 | 2019-2025 | Camzyos, Eliquis |
| Actelion Pharmaceuticals US, INC. | $1,141.46 | 2020-2025 | Uptravi, Opsumit, Opsynvi |
| Merck Sharp & Dohme LLC | $1,066.56 | 2019-2025 | Verquvo, Winrevair, Capvaxive |
| Novartis Pharmaceuticals Corporation | $972.22 | 2019-2025 | Leqvio |
| Abbott Laboratories | $942.92 | 2019-2025 | Aveir, Triclip, Mitraclip |
| Esperion Therapeutics, INC. | $838.55 | 2020-2024 | Nexletol, Nexlizet |
| Boehringer Ingelheim Pharmaceuticals, INC. | $632.48 | 2019-2025 | Jardiance |
| Amarin Pharma, INC. | $580.85 | 2019-2023 | |
| Biotronik Nro, INC. | $562.01 | 2023-2025 | Prospera, Biotronik |
Show all 59 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $431.70 | 2019-2025 | Lifevest |
| Sanofi-Aventis U.S. LLC | $410.51 | 2019-2023 | |
| Edwards Lifesciences Corporation | $368.22 | 2023-2025 | Edwards Sapien 3 Transcatheter Heart Valve (Thv) |
| Lilly USA, LLC | $337.50 | 2019-2024 | Mounjaro |
| Abbvie INC. | $332.63 | 2021-2023 | |
| Pfizer INC. | $323.97 | 2019-2025 | |
| Bayer Healthcare Pharmaceuticals INC. | $313.34 | 2024-2025 | |
| Arbor Pharmaceuticals, INC. | $275.40 | 2019-2021 | |
| Kowa Pharmaceuticals America, INC. | $274.59 | 2019-2023 | Livalo, Seglentis |
| Cvrx, INC. | $267.69 | 2023-2024 | Barostim Neo System |
| Shockwave Medical, INC | $252.97 | 2025 | |
| Abiomed | $220.91 | 2024-2025 | Impella |
| Paratek Pharmaceuticals, INC. | $201.77 | 2023 | Nuzyra |
| Irhythm Technologies, INC. | $184.36 | 2020-2024 | Zio Xt Patch, Zio Monitor |
| Lexicon Pharmaceuticals, INC. | $169.63 | 2023-2024 | Inpefa |
| Scpharmaceuticals INC. | $167.23 | 2024-2025 | |
| Medicure Pharma INC. | $163.83 | 2020-2024 | Zypitamag |
| Chiesi USA, INC. | $134.62 | 2019-2025 | Kengreal |
| Impulse Dynamics (USA) INC. | $132.68 | 2022 | |
| Hydrocision, INC. | $131.74 | 2024 | Tenjet |
| Atricure, INC. | $111.04 | 2023 | |
| Agepha Pharma Fz LLC | $109.90 | 2024-2025 | Lodoco |
| Vifor Pharma, INC. | $84.76 | 2019-2021 | |
| Currax Pharmaceuticals LLC | $66.10 | 2020-2023 | Contrave |
| Lundbeck LLC | $56.66 | 2019-2020 | |
| Regeneron Pharmaceuticals, INC. | $54.51 | 2019 | |
| Mml US, INC. | $53.04 | 2022-2024 | Reactiv8 |
| Digirad Health, INC | $45.10 | 2025 | Cardius |
| Medtronic Vascular, INC. | $41.48 | 2019 | |
| Genzyme Corporation | $35.56 | 2020-2021 | |
| Bridgebio Pharma, INC. | $34.47 | 2025 | Attruby |
| Kiniksa Pharmaceuticals, Ltd. | $30.01 | 2023 | Arcalyst |
| Idorsia Pharmaceuticals US INC | $27.33 | 2023-2024 | Quviviq |
| W. L. Gore & Associates, INC. | $27.00 | 2025 | Gore Cardioform Septal Occluder |
| Pacira Pharmaceuticals Incorporated | $25.86 | 2023 | Iovera, Zilretta |
| Tactile Systems Technology INC | $24.07 | 2020 | |
| Glaxosmithkline, LLC. | $21.03 | 2025 | Arexvy, Shingrix |
| Azurity Pharmaceuticals, INC. | $19.78 | 2023 | Horizant |
| Teleflex LLC | $18.65 | 2025 | Manta |
| Amryt Pharma Holdings Ltd | $18.07 | 2022 | |
| Preventice Services, LLC | $17.56 | 2021 | |
| Gilead Sciences, INC. | $17.25 | 2019 | |
| Bardy Diagnostics, INC. | $15.00 | 2020 | |
| Regeneron Healthcare Solutions, INC. | $12.45 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Anthony Gunawan listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.